Zynerba Pharmaceuticals Announces Panel Presentation And Poster Presentations At The NFXF International Fragile X Conference
Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, today announced two poster